PMN Stock

Leede Jones Gable analyst Douglas W. Loe reiterated a “Speculative Buy” rating on drug developer... Read More

Drug developer ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Charts, News, Analysts, Finan... Read More

Leede Jones Gable analyst Douglas Loe provided an update on Wednesday on drug developer ProMIS Neuro... Read More

Analyst Douglas Loe and Leede Jones Gable have launched coverage on ProMIS Neurosciences (Promis Neu... Read More

In a client update on Thursday, Mackie Research analyst André Uddin has changed his rating for biot... Read More

An Alzheimer’s drug trial failure has caused Mackie Research analyst André Uddin to downgrade his... Read More

In an update to clients on Wednesday, Mackie Research analyst André Uddin gives a review of Promis ... Read More